comparemela.com

Latest Breaking News On - Nutrition survey jan feb - Page 1 : comparemela.com

Anatara Lifesciences Ltd (ASX:ANR) Market Update - ABN Newswire (@ABN_Newswire)

Anatara Lifesciences Ltd (ASX:ANR) Market Update    Market UpdateMelbourne, April 7, 2021 AEST (ABN Newswire) - Anatara Lifesciences Ltd ( ASX:ANR) provides an update on development and commercialisation activities for human health and animal health projects. Anatara is pleased that activities for the March quarter progressed favourably and near to anticipated timelines. There appears to be a wider appreciation of Anatara s human health initiatives with a focus on using the restoration and/or maintenance of gastrointestinal tract harmony to improve overall wellbeing and with a market differentiating focus on evidence based complementary medicine. Anatara has ethics approval to commence the human clinical trial in irritable bowel syndrome (IBS) with Anatara s Gastrointestinal ReProgramming (GaRP) complementary medicine. Due to a scheduling delay in manufacturing placebo for this trial as a result of reduced shifts under covid restrictions, the Company now anticipates comme

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.